Wordt geladen...
Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
BACKGROUND/AIMS: The dose of mycophenolate mofetil (MMF) has been reduced in Asia due to side effects associated with the conventional fixed dose of 2-3 g/day. We aimed to determine the pharmacokinetics of a reduced dose of MMF and to validate its feasibility in combination with tacrolimus in living...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
The Korean Association for the Study of the Liver
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4197178/ https://ncbi.nlm.nih.gov/pubmed/25320733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2014.20.3.291 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|